Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Grasping Nanotech Is A Piece Of Cake With Physicist’s “Twinkie Guide”

This article was originally published in The Rose Sheet

Executive Summary

Andrew Maynard, Ph.D., chief science advisor to the Project on Emerging Nanotechnologies, delivers a lesson on nanotechnology by drawing comparisons to a beloved American snack cake in his video presentation "The Twinkie Guide to Nanotechnology.

You may also be interested in...



EC Advises Against Studying Nano-Cosmetics In Humans Until Risks Are Known

Researchers should avoid clinical studies on nano-based cosmetics until more is known about their long-term effects, according to a Recommendation issued Feb. 7 by the European Commission (EC)

EC Advises Against Studying Nano-Cosmetics In Humans Until Risks Are Known

Researchers should avoid clinical studies on nano-based cosmetics until more is known about their long-term effects, according to a Recommendation issued Feb. 7 by the European Commission (EC)

Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition

FDA should amend the OTC final sunscreen monograph to specify that products containing engineered nanoparticles are excluded and designate the formulas "new drugs," a coalition of public interest groups states in a citizen petition

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015082

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel